Horizon Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25.8M | Buy |
103,457
+14,037
| +16% | +$3.02M | 0.28% | 68 |
|
|
2026
Q1 | $19.3M | Sell |
89,420
-50,221
| -36% | -$11.1M | 0.22% | 80 |
|
|
2025
Q4 | $31.7M | Buy |
139,641
+59,618
| +75% | +$13.6M | 0.4% | 40 |
|
|
2025
Q3 | $18.4M | Buy |
80,023
+24,756
| +45% | +$5.04M | 0.24% | 77 |
|
|
2025
Q2 | $10.2M | Buy |
55,267
+33,276
| +151% | +$6.18M | 0.16% | 104 |
|
|
2025
Q1 | $4.57M | Buy |
21,991
+830
| +4% | +$161K | 0.14% | 97 |
|
|
2024
Q4 | $3.73M | Buy |
21,161
+617
| +3% | +$113K | 0.11% | 112 |
|
|
2024
Q3 | $4.02M | Buy |
20,544
+8,719
| +74% | +$1.63M | 0.11% | 100 |
|
|
2024
Q2 | $2.01M | Sell |
11,825
-13,905
| -54% | -$2.3M | 0.06% | 160 |
|
|
2024
Q1 | $4.64M | Buy |
25,730
+1,080
| +4% | +$186K | 0.12% | 90 |
|
|
2023
Q4 | $3.78M | Sell |
24,650
-7,964
| -24% | -$1.16M | 0.11% | 91 |
|
|
2023
Q3 | $4.81M | Buy |
32,614
+447
| +1% | +$65.6K | 0.15% | 72 |
|
|
2023
Q2 | $4.29M | Sell |
32,167
-2,241
| -7% | -$329K | 0.12% | 73 |
|
|
2023
Q1 | $5.43M | Buy |
34,408
+6,488
| +23% | +$992K | 0.16% | 65 |
|
|
2022
Q4 | $4.47M | Buy |
27,920
+18,186
| +187% | +$2.79M | 0.13% | 78 |
|
|
2022
Q3 | $1.29M | Sell |
9,734
-46,476
| -83% | -$6.67M | 0.04% | 166 |
|
|
2022
Q2 | $8.53M | Sell |
56,210
-2,750
| -5% | -$420K | 0.27% | 39 |
|
|
2022
Q1 | $9.48M | Buy |
58,960
+25,760
| +78% | +$3.74M | 0.27% | 46 |
|
|
2021
Q4 | $4.45M | Buy |
33,200
+21,082
| +174% | +$2.49M | 0.13% | 84 |
|
|
2021
Q3 | $1.29M | Sell |
12,118
-34,990
| -74% | -$4M | 0.03% | 188 |
|
|
2021
Q2 | $5.25M | Sell |
47,108
-11,424
| -20% | -$1.29M | 0.16% | 70 |
|
|
2021
Q1 | $6.33M | Buy |
+58,532
| New | +$6.26M | 0.23% | 49 |
|
|
2020
Q4 | – | Sell |
-45,940
| Closed | -$3.97M | – | 95 |
|
|
2020
Q3 | $3.97M | Sell |
45,940
-27,842
| -38% | -$2.62M | 0.14% | 77 |
|
|
2020
Q2 | $7.16M | Buy |
73,782
+24,110
| +49% | +$2.12M | 0.18% | 61 |
|
|
2020
Q1 | $3.73M | Buy |
49,672
+30,505
| +159% | +$2.6M | 0.18% | 44 |
|
|
2019
Q4 | $1.7M | Buy |
19,167
+12,528
| +189% | +$1.04M | 0.07% | 126 |
|
|
2019
Q3 | $495K | Buy |
6,639
+638
| +11% | +$43.7K | 0.02% | 163 |
|
|
2019
Q2 | $436K | Buy |
6,001
+569
| +10% | +$44.7K | 0.01% | 281 |
|
|
2019
Q1 | $432K | Buy |
5,432
+3,214
| +145% | +$263K | 0.02% | 217 |
|
|
2018
Q4 | $204K | Buy |
+2,218
| New | +$195K | 0.01% | 195 |
|
Other funds holding ABBV
Horizon Investments's ABBV Position: Q2 2026 in Review
Horizon Investments increased its AbbVie (ABBV) stake by 16% in Q2 2026, buying an estimated $3.02M and bringing the position to 103,457 shares worth $25.8M. The position accounts for 0.28% of the portfolio, ranked #68.
Horizon Investments first reported a position in ABBV in Q4 2018 and has held it in 30 quarters since. The position peaked at $31.7M in Q4 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Horizon Investments held 103,457 shares of AbbVie worth $25.8M as of Q2 2026.
- Horizon Investments bought 14,037 AbbVie shares in Q2 2026, an estimated $3.02M.
- AbbVie made up 0.28% of Horizon Investments's portfolio in Q2 2026, its #68 holding.
- Horizon Investments first reported a position in AbbVie in Q4 2018 and has held it in 30 quarters since.
- Horizon Investments's AbbVie position peaked at $31.7M in Q4 2025.
- 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.